Literature DB >> 34330234

Effect of spectral CT on tumor microvascular angiogenesis in renal cell carcinoma.

Bei Zhang1, Qiong Wu2, Xiang Qiu1, Xiaobo Ding1, Jin Wang3, Jing Li1, Pengfei Sun1, Xiaohan Hu4.   

Abstract

BACKGROUND: To examine the value of energetic-spectrum computed tomography (spectral CT) quantitative parameters in renal cell carcinoma (RCC) microvascular angiogenesis.
METHODS: The authors evaluated 32 patients with pathologically confirmed RCC who underwent triple-phase contrast-enhanced CT with spectral CT imaging mode from January 2017 to December 2019. Quantitative parameters include parameters derived from iodine concentration (IC) and water concentration (WC) of 120 keV monochromatic images. All specimens were evaluated including the microvascular density (MVD), microvascular area (MVA) and so on. The correlation between IC and WC (including average values and random values) with microvascular parameters were analyzed with Pearson or Spearman rank correlation coefficients.
RESULTS: The MVD of all tumors was 26.00 (15.00-43.75) vessels per field at × 400 magnification. The MVD of RCC correlated positively with the mean IC, mean WC, mean NWC, mean NIC, random IC, random NIC in renal cortical phase, WCD1, WCD2, NWCD2 and ICD1 (Spearman rank correlation coefficients, r range, 0.362-0.533; all p < 0.05). The MVA of all tumors was (16.16 ± 8.98) % per field at × 400 magnification. The MVA of RCC correlated positively with the mean IC, mean WC, mean NWC, mean NIC, random IC, random NIC in renal cortical, mean WC and mean NWC in renal parenchymal phase, WCD1, WCD2, WCD3, NWCD2, and NWCD3 (Pearson or Spearman rank correlation coefficients, r range, 0.357-0.576; all p < 0.05). Microvascular grading correlated positively with the mean NWC, mean NIC and random NIC in renal cortical phase, mean NWC in renal parenchymal phase, NWCD2, WCD3, NWCD3, NICD2 and NICD3 (Spearman rank correlation coefficients, r range, 0.367-0.520; all p < 0.05). As for tumor diameter (55.19 ± 19.15), μm, only NWCD3 was associated with it (Spearman rank correlation coefficients, r = 0.388; p < 0.05).
CONCLUSIONS: ICD and WCD of spectral CT have a potential for evaluating RCC microvascular angiogenesis. MVD, MVA and microvascular grade showed moderate positive correlation with ICD and WCD. ICD displayed more relevant than that of WCD. The parameters of renal cortical phase were the best in three phases. NICD and NWCD manifested stronger correlation with microvascular parameters than that of ICD and WCD.
© 2021. The Author(s).

Entities:  

Keywords:  Angiogenesis; Dual-energy CT; Microvessel angiogenesis; Quantitative imaging; Renal cell carcinoma

Year:  2021        PMID: 34330234     DOI: 10.1186/s12885-021-08586-x

Source DB:  PubMed          Journal:  BMC Cancer        ISSN: 1471-2407            Impact factor:   4.430


  23 in total

1.  Microvessels in Epithelial Ovarian Tumors: High Microvessel Density Is a Significant Feature of Malignant Ovarian Tumors.

Authors:  Minna Sopo; Maarit Anttila; Oona-Tuuli Muukkonen; Seppo YlÄ-Herttuala; Veli-Matti Kosma; Leea Keski-Nisula; Hanna Sallinen
Journal:  Anticancer Res       Date:  2020-12-07       Impact factor: 2.480

2.  Molecular epidemiology of VHL gene mutations in renal cell carcinoma patients: relation to dietary and other factors.

Authors:  Kari Hemminki; Yongwen Jiang; Xin Ma; Ke Yang; Lars Egevad; Per Lindblad
Journal:  Carcinogenesis       Date:  2002-05       Impact factor: 4.944

3.  Papillary vs clear cell renal cell carcinoma. Differentiation and grading by iodine concentration using DECT-correlation with microvascular density.

Authors:  Julian Marcon; Anno Graser; David Horst; Jozefina Casuscelli; Annabel Spek; Christian G Stief; Maximilian F Reiser; Johannes Rübenthaler; Alexander Buchner; Michael Staehler
Journal:  Eur Radiol       Date:  2019-07-05       Impact factor: 5.315

4.  Iodine Parameters in Triple-Bolus Dual-Energy CT Correlate With Perfusion CT Biomarkers of Angiogenesis in Renal Cell Carcinoma.

Authors:  Dinesh Manoharan; Arjunlokesh Netaji; Chandan J Das; Sanjay Sharma
Journal:  AJR Am J Roentgenol       Date:  2020-02-18       Impact factor: 3.959

Review 5.  Review of Prognostic Expression Markers for Clear Cell Renal Cell Carcinoma.

Authors:  Florent Petitprez; Mira Ayadi; Aurélien de Reyniès; Wolf H Fridman; Catherine Sautès-Fridman; Sylvie Job
Journal:  Front Oncol       Date:  2021-04-28       Impact factor: 6.244

Review 6.  Pulmonary metastasectomy in renal cell carcinoma: a mainstay of multidisciplinary treatment.

Authors:  Joseph Seitlinger; Mathilde Prieto; Joelle Siat; Stéphane Renaud
Journal:  J Thorac Dis       Date:  2021-04       Impact factor: 2.895

7.  FORCE dual-energy CT in pathological grading of clear cell renal cell carcinoma.

Authors:  Chunling Zhang; Ning Wang; Xinyou Su; Kun Li; Dexin Yu; Aimei Ouyang
Journal:  Oncol Lett       Date:  2019-10-30       Impact factor: 2.967

8.  Assessment of tissue perfusion of pancreatic cancer as potential imaging biomarker by means of Intravoxel incoherent motion MRI and CT perfusion: correlation with histological microvessel density as ground truth.

Authors:  Miriam Klauß; Wolfram Stiller; Philipp Mayer; Franziska Fritz; Marco Koell; Stephan Skornitzke; Frank Bergmann; Matthias M Gaida; Thilo Hackert; Klaus Maier-Hein; Frederik B Laun; Hans-Ulrich Kauczor; Lars Grenacher
Journal:  Cancer Imaging       Date:  2021-01-19       Impact factor: 3.909

9.  Renal cell carcinoma: Associations between tumor imaging features and epidemiological risk factors.

Authors:  Andreas M Hötker; Christoph A Karlo; Pier Luigi Di Paolo; Junting Zheng; Chaya S Moskowitz; Paul Russo; Hedvig Hricak; Oguz Akin
Journal:  Eur J Radiol       Date:  2020-05-30       Impact factor: 3.528

10.  The Clinicopathologic and Molecular Landscape of Clear Cell Papillary Renal Cell Carcinoma: Implications in Diagnosis and Management.

Authors:  Stanley Weng; Renzo G DiNatale; Andrew Silagy; Roy Mano; Kyrollis Attalla; Mahyar Kashani; Kate Weiss; Nicole E Benfante; Andrew G Winer; Jonathan A Coleman; Victor E Reuter; Paul Russo; Ed Reznik; Satish K Tickoo; A Ari Hakimi
Journal:  Eur Urol       Date:  2020-10-10       Impact factor: 20.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.